About TropoFlex™
TropoFlex Inc., is a Texas Based C corporation led by a team of seasoned executives with an established track record of innovation, value creation, product development and successful exits.
TropoFlex’ mission is to revolutionize equine lameness treatment modalities through its innovative collagen regeneration technology. We are aiming to become the leading treatment solution for soft tissue injuries and degenerative joint disease, including osteoarthritis, the leading cause of lameness from joint, tendon and ligament injuries.
TropoFlex’ patented injectable formulation specifically enhances the generation of new collagen proteins through the direct delivery of Tropocollagen, the precursor to collagen formation. Our unique and patented formulation of precisely sequenced amino acid residues is delivered minimally invasively by injection and stimulates natural collagen biosynthesis, enhancing collagen maturation and tissue integrity.
